{{Drugbox
| Watchedfields = changed
| verifiedrevid = 447574259
| IUPAC_name = (8β)-6-Methyl-8-(morpholin-4-ylcarbonyl)-9,10-didehydroergoline
| image = LSM-775.svg
| width = 200

<!--Clinical data-->
| tradename = 
| legal_AU = 
| legal_CA = 
| legal_UK = 
| legal_US = 
| routes_of_administration = [[wikt:oral|Oral]]

<!--Pharmacokinetic data-->
| metabolism = hepatic
| excretion = renal

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 4314-63-0
| PubChem = 199507
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 172695

<!--Chemical data-->
| C=20 | H=23 | N=3 | O=2
| molecular_weight = 337.43 g/mol
| smiles = O=C(N1CCOCC1)[C@@H]5/C=C4/c2cccc3c2c(cn3)C[C@H]4N(C)C5
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H23N3O2/c1-22-12-14(20(24)23-5-7-25-8-6-23)9-16-15-3-2-4-17-19(15)13(11-21-17)10-18(16)22/h2-4,9,11,14,18,21H,5-8,10,12H2,1H3/t14-,18-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OTQWCDNEJVKXKG-RDTXWAMCSA-N
| synonyms = LSM-775, N-Morpholinyllysergamide, Lysergic acid morpholide
}}

'''''N''-Morpholinyllysergamide''' ('''LSM-775''') is a derivative of [[ergine]].<ref>{{cite journal | url=http://jpet.aspetjournals.org/content/120/3/340.abstract | title=Pharmacology of d-lysergic acid morpholide (LSM) | author=John H. Gogerty, James M. Dille | journal=The Journal of Pharmacology and Experimental Therapeutics | date=July 1957 | volume=120 | issue=3 | pages=340–348 | pmid=13476356}}</ref> It is reported to have some [[Lysergic acid diethylamide|LSD]]-like effects at doses ranging from 75 to 700 micrograms and a shorter duration. There are fewer signs of cardiovascular stimulation and peripheral toxicity with LSM-775 compared to LSD-25.<ref name="TiHKAL">{{cite web |url = https://www.erowid.org/library/books_online/tihkal/tihkal26.shtml|title = TiHKAL #26, LSD-25|publisher = Erowid|author = Alexander and Ann Shulgin}}</ref>

==References==
{{reflist}}

{{DEFAULTSORT:LSM-775}}
{{Hallucinogens}}
{{Serotonergics}}
{{Ergolines}}

[[Category:Lysergamides]]
[[Category:Morpholines]]
[[Category:Serotonin receptor agonists]]
[[Category:Designer drugs]]

{{hallucinogen-stub}}